Clinical Trials Browser

Phase 1 × Interventional × IPH-2101 × Clear all

NCT00552396 2016-03-31

An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma

Phase 1 Completed

32 enrolled 16 charts

Multiple Myeloma